(Total Views: 684)
Posted On: 04/06/2022 6:34:15 PM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Far be it for me to be the voice of reason, but haven't we been down this road? What you are suggesting, is it not a bad idea?
I believe there is a concern that empirical safety data does not exist for this leronlimab.
Are there any randomized, double blind, controlled studies of significant size that prove efficacy?
Moreover, is there not a concern that the first FDA letter was prompted by investors and friends of Leronlimab badgering political officials?
I believe there is a concern that empirical safety data does not exist for this leronlimab.
Are there any randomized, double blind, controlled studies of significant size that prove efficacy?
Moreover, is there not a concern that the first FDA letter was prompted by investors and friends of Leronlimab badgering political officials?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)